Cuprina Holdings is trading at $2.08, down 18.43%, with no clear company-specific catalyst identified for the October 2 decline.

  • An October 2 report announced an agreement to acquire two Singapore clinics for about S$4 million, without linking it to the decline.
  • Recent major coverage described the pullback as unexplained; major indices were higher, so broad-market weakness did not explain the move.
  • Shares rose 11.84% on October 1 after four consecutive advancing sessions, marking a sharp reversal.